Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and growth in obese children before and after reduction of overweight

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 3, 2009, Pages 225-233

  Reinehr, Thomas ^a   Panteliadou, Aikaterini ^a   de Sousa, Gideon ^a   Andler, Werner ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Children; IGF I; IGFBP 3; Insulin; Leptin; Obesity; Weight loss

Indexed keywords

INSULIN; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GROWTH DISORDER; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; LIFESTYLE MODIFICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TALL STATURE; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 65349153126     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.3.225     Document Type: Article

References (40)

1. Argente J, Caballo N, Barrios V, Pozo J, Muñoz MT, Chowen JA, Hernández M. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab 1997; 82: 2076-2083.
2. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity and aging. Metabolism 1990; 39: 584-587.
3. Minuto F, Barreca A, Del-Monte P, Fortini P, Resentini M, Morabito F, Giordano G. Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty. J Endocrinol Invest 1988; 11: 489-495.
4. Rosskamp R, Becker M, Soetadji S. Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children. Eur J Pediatr 1987; 146: 48-50.
5. Hochberg Z, Hertz P, Colin V. The distal axis of growth hon-none (GH) in nutritional disorders: GH binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992; 41: 106-112.
6. Wabitsch M, Blum WF, Muche R, Heinze E, Haug C, Mayer H, Teller W. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. Int J Obes 1996; 20: 1073-1080.
7. Park MJ, Kim HS, Kang JH, Kim DH, Chung CY. Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children. J Clin Endocrinol Metab 1999; 12: 139-144.
8. Saitoh H, Kamoda T, Nakahara S, Hirano T, Nakamura N. Serum concentrations of insulin, insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children. Clin Endocrinol (Oxf) 1998; 48: 487-492.
9. Woelfle JF, Harz K, Roth C. Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children. Exp Clin Endocrinol Diabetes 2007; 115: 17-23.
10. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jørgensen K, Müller J, Hall K, Skakkebaek NE. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994; 78: 744-752.
11. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995; 80: 2534-2542.
12. Frystyk J, Vestbo E, Skjaerbaek C, Morgensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1985; 44: 37-44.
13. Nam SY, Lee, EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Effect of obesity on total and free insulin-like growth factor (IGF)-1 and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin and growth hormone. Int J Obes 1997; 21: 355-359.
14. Rasmussen MH, Juul A, Kjems LL, Skakkebaek NE, Hilsted J. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J Clin Endocrinol Metab 1995; 80: 796-801.
15. Holl RV, Snehotta R, Scherbaum W, Heintze E. Binding protein for human growth hormone: effects of age and weight. Horm Res 1991; 35: 190-197.
16. Rasmussen MH, Ho KKY, Kjems L, Hilsted J. Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss. J Clin Endocrinol Metab 1995; 81: 1519-1524.
17. Reinehr T, de Sousa G, Wabitsch M. Relationships of IGF-I and androgens to skeletal maturation in obese children and adolescents. J Pediatr Endocrinol Metab 2006; 19: 1133-1140.
18. Russell DL, Keil MF, Bonat SH, Uwaifo GI, Nicholson JC, McDuffie JR, Hill SC, Yanovski JA. The relation between skeletal maturation and adiposity in African American and Caucasian children. J Pediatr 2001; 139: 844-848.
19. Klein KO, Larmore KA, Lancey E, Brown JM, Considine RV, Hassink SG. Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 1998; 83: 3469-3475.
20. Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1982; 55: 999-1002.
21. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995; 80: 443-449.
22. Falorni A, Bini V, Cabiati G, Papi F, Arzano S, Celi F, Sanasi M. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status. Metabolism 1997; 46: 862-871.
23. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
24. Kromeyer-Hauschild K, Wabitsch M, Geller F, Ziegler A, Geiß HC, Hesse V, v. Hippel, Jaeger U, Johnsen D, Kiess W, Korte W, Kunze D, Menner K, Müller M, Niemann-Pilatus A, Remer Th, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Hebebrand J. Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807-818.
25. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45-60.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
27. Reinehr T, de Sousa G, Toschke M, Andler W. Long-term follow-up of cardiovascular disease risk factors in obese children after intervention. Am J Clin Nutr 2006; 84: 490-496.
28. Reinehr T, Andler W. Changes in the atherogenic risk-factor profile according to degree of reduction of overweight. Arch Dis Child 2004; 89: 419-422.
29. Woelfle J, Chia DJ, Rotwein P, Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 2003; 278: 51261-51266.
30. Phillip M, Moran O, Lazar L. Growth without growth hormone. J Pediatr Endocrinol Metab 2002; 15 (Suppl 5): 1267-1272.
31. Conover CA, Lee PDK, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355-1360.
32. de Simone M, Farello G, Palumbo M, Gentile T, Ciuffreda M, Olioso P, Cinque M, De Matteis F. Growth charts, growth velocity and bone development in childhood obesity. Int J Obes Relat Metab Disord 1995; 19: 851-857.
33. He Q, Karlberg J. BMI in childhood and its association with height gain, timing of puberty, and final height. Pediatr Res 2001; 49: 244-251.
34. Dietz WH, Hartung R. Changes in height velocity of obese preadolescents during weight reduction. Am J Dis Child 1985; 139: 705-707.
35. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994; 15: 80-101.
36. Gama R, Teale JD, Marks V. The effect of synthetic very low calorie diets on the GH-IGF-I-axis in obese subjects. Clin Chim Acta 1990; 188: 31-38.
37. Musey VC, Goldstein S, Farmer PK, Moore PB, Phillips LS. Differential regulation of IGF-1 and IGF-binding protein-1 by dietary composition in humans. Am J Med Sci 1993; 305: 131-138.
38. Figueroa-Colon R, von Almen TK, Franklin FA, Schuftan C, Suskind RM. Comparison of two hypocaloric diets in obese children. Am J Dis Child 1993; 147: 160-166.
39. Epstein LH, McCurley J, Valoski A, Wing RR. Growth in obese children treated for obesity. Am J Dis Child 1990; 144: 1360-1364.
40. Falorni A, Galmacci G, Bini V, Faraoni F, Molinari D, Cabiati G, Sanasi M, Celi F, Di Stefano G, Berioli MG, Contessa G, Bacosi ML. Using obese-specific charts of height and height velocity for assessment of growth in obese children and adolescents during weight excess reduction. Eur J Clin Nutr 1999; 53: 181-188.